Biotech News

Thur Dec 17, 2009 10:55am EST - Decode Genetics new pharmaceutical research laboratory and North American headquarters in Woodbridge, Illinois.

We sweat, we diet -- we try all sorts of things to lose weight -- but the way we think about weight loss may be about to dramatically change.

In this April 15, 2009 photo, a security guard stands in the lobby of Merck & Company, Inc.'s world headquarters in Whitehouse Station, N.J. Merck&Co. said Thursday it is making another deal in its strategy to become a top maker of biotech drugs, buying a British company that makes them.

Diversified health care company Johnson & Johnson said Wednesday its Ethicon unit will buy privately held medical technology company Acclarent Inc.

After weeks of shortages, swine flu vaccine is plentiful enough that nearly half the states now say everyone can get it, not just people in high-risk groups.

Dec. 16 -- Anthony Coles, chief executive officer of Onyx Pharmaceuticals Inc., talks with Bloomberg's Pimm Fox about tests Onyx says show their Nexavar pill extended the lives of women with advanced breast cancer.

Federal health advisers recommended Wednesday against expanding approval of an OSI Pharmaceuticals lung cancer drug to patients who are already responding to chemotherapy.

Auxilium Pharmaceuticals Inc. said Wednesday its drug candidate Xiaflex met a key treatment goal in a midstage study focused on Peyronie's disease, or penile curvature.

The number of households with cell phones but no landlines continues to grow, but the recession doesn't seem to be forcing poor cellular users to abandon their traditional wired phones any faster than higher-income people are.

Sol Price, the founder of Price Club who helped pioneer the warehouse superstore sales model that grew into a multibillion-dollar industry, died Monday.

Home sales in Los Angeles County rose by 24.2 percent in November, compared to the same month a year ago, but prices fell by 3.2 percent, a real estate information service reported today.

Biotech drug developer Amgen Inc. has entered an agreement with Array BioPharma Inc.

Elan Corp. Plc and Transition Therapeutics Inc. said Tuesday they've eliminated two of three doses used in a mid-stage study of a potential Alzheimer's disease treatment after nine patients died while receiving the higher doses.

Dec 15, 2009 - Gilead Sciences, Inc. today announced that DAR-312 , a Phase III clinical trial evaluating darusentan, the company's endothelin receptor antagonist for the treatment of resistant hypertension, did not achieve its co-primary efficacy endpoints of change from baseline to week 14 in trough sitting systolic blood pressure and diastolic ...

In this file photo, people work during a dry run in the influenza vaccine harvesting suite at Sanofi Pasteur in Swiftwater, Pa.

Abbott announced today a definitive agreement to acquire STARLIMS Technologies Ltd.

The board of directors of Pfizer Inc. today declared an 18-cent first-quarter 2010 dividend on the companya s common stock, payable March 2, 2010, to shareholders of record at the close of business on February 5, 2010.

The U.S. Food and Drug Administration approved ZYPREXA RELPREVV For Extended Release Injectable Suspension for the treatment of schizophrenia in adults, Eli Lilly and Company announced today.

Hyderabad, Dec 14: IT services innovator Bodhtree Consulting Monday announced that Dr.

About 300 guests have been relocated from a luxury Miami hotel after one guest died and at least two others became sick from a bacteria in the water.